 | BONDS OVERSHADOW STOCKS By Charles Payne, CEO & Principal Analyst
3/10/2010 2:00:19 PM Eastern
Time
It has been one of those days where the market wanted to breakout but never got the news that could have provided a spark. In fact,
equities took a backseat to bonds both domestically and abroad.
* U.S. 10-year Treasury auction of $21.0 billion * Portugal raised $1.34
billion as investors bid for $2.15 billion April 2021 @4.17% * Citigroup $2.0 billion 8.5% 30-year TruPS * Novartis raised $5.0 billion *
MGM raised $845.0 million through a 10-year bond issuance
A pullback in foreign demand actually knocked the so-so equity rally off the rails.
Additional News Items
Wholesale trade saw sales continue to edge higher while inventories continue to decrease.

There was much greater petroleum demand than anticipated as
crude inventories climbed less than expected while gasoline and distillates experienced greater draw downs.

Does it Make Sense to be Mechanistic in One's Investment
Style? By: Brian Sozzi, Research Analyst
I think over a long period of time, the "Dogs of the Dow" or other mechanistic
investment approaches becomes a crowded trade. By noting this I mean the more investors get into such stocks in the search for yield, the price of the
stock should theoretically go higher, thus reducing the yield. With yield declining, it reduces the attractiveness, or the very point of, the "Dogs of
the Dow" or other mechanistic investment approaches. I would think that perhaps those Dogs have less of a propensity to raise dividends given that
their operations are not as healthy as others in the Dow, helping to explain their higher yield from the onset. I suppose there is a law of
diminishing returns at play with regards to mechanistic approaches to investing.
I would rather put money to work in those companies that are
demonstrating a strong probability for a dividend reinstatement or dividend increase. It would be these companies that are likely to experience
stronger equity prices given their stronger earnings power. By extension, that free cash flow could be plowed (or reinvested) back into new growth
assets (in retail, it would be new stores or technology to drive efficiencies from existing stores and distribution) or returned to shareholders.
Again, investors here would enjoy share price appreciation in the early years of high growth in earnings followed by the arrival of dividends as the
business matures and growth slows.
| Delivery, and or timely
delivery of Internet mail is not guaranteed. Wall Street Strategies therefore recommends that you do not rely on email as your sole method of
communication with us. We recommend using your company email address or one issued to you by your Internet Service Provider. Free web-based email
accounts like Hotmail and Yahoo are not advised as they are subject to quotas, filters and frequent delays.
Disclaimer: All investment entails
inherent risk. Wall Street Strategies' research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits
or minimize losses. All final investment decisions are yours and as a result you could make or lose money. Wall Street Strategies, its employees
and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities
discussed. Wall Street Strategies, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of
the covered company nor does any employee of Wall Street Strategies sit on the Board of Directors of any covered company. Wall Street Strategies is
not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein
include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy
or completeness. The statements made herein contain general information and do not constitute an offer to buy or sell any security.
61
BROADWAY SUITE 1425, NEW YORK, NY 10006 Tel: 212-514-9500 Fax: 212-514-9582 | | | | This email was sent to
- 82671 |
|